Found 4 matching trials
STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY PHASE1 The purpose of the study is to evaluate the effect of formulation on relati...
Show More Location
Brussels Clinical Research Unit
Learn More & Join Trial
A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY PHASE2 This study will assess tolerability, safety, and pharmacodynamics (PD) of t...
Show More Location
Arizona Research Center
Learn More & Join Trial
4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes PHASE1 This is a dose-escalating study in patients with Type 2 diabetes on metform...
Show More Location
Anaheim Clinical Trials, LLC
Learn More & Join Trial
Study To Characterize Mass Balance, Absolute Bioavailability, Fraction Absorbed And Pharmacokinetics Of 14C PF-06882961 PHASE1 This study is a Phase 1, open-label, non-randomized, 2-period, fixed sequen...
Show More Location
PRA Health Sciences
Learn More & Join Trial